基于NMR的长度新陈代谢突出显示了ARDS患者和无败血症患者的共同病理生理机制
Anamika Singh1,2, Mohd Adnan Siddiqui1, Afzal Azim3
1Centre of Biomedical Research, SGPGIMS Campus, Lucknow, India.
Magnetic resonance in chemistry : MRC
|September 4, 2025
概括
有或没有败血症的急性呼吸困难综合征 (ARDS) 具有相似的代谢特征. 这表明统一的治疗方法可以改善ARDS患者的临床结果.
科学领域:
- * 临床护理医学
- * 呼吸系统医学
- * 临床生物化学
背景情况:
- * 急性呼吸困难综合征 (ARDS) 是一种严重的疾病,经常因败血症而复杂,影响患者的预后.
- * 生物标志物在有或没有败血症的ARDS区分中的有用性需要进一步研究.
- * 了解代谢差异对于有针对性的治疗策略至关重要.
研究的目的:
- * 为了比较ARDS患者的血清代谢物概况,有或没有败血症,在ICU的两个时间点 (第1天和第7天).
- * 调查代谢特征与临床结果之间的关联,包括死亡率.
- * 为了确定区分ARDS亚型的潜在生物标志物.
主要方法:
- * 研究了一组151名ARDS患者,在1日 (n=91) 和7日 (n=60) 收取血清样本.
- * 血清样本经过基于1H NMR的代谢组测试,以确定和量化代谢物.
- * 收集了临床数据和死亡率,并分析了与代谢发现的相关性.
主要成果:
- 在第1天和第7天,在ARDS患者和没有败血症患者之间没有观察到血清代谢物概况的显著差异.
- * 两组患者在第7天的死亡率相似 (50%的存活率).
- * 在有败血症和没有败血症的ARDS组之间,临床特征没有显著差异.
结论:
- * ARDS,不论是败血症的同时感染,都呈现出类似的代谢特征.
- * 共同的病理生理机制可能是可比代谢特征的基础.
- * 针对ARDS的统一治疗策略,不论是败血症状态如何,都可能有助于改善患者的治疗结果.
相关概念视频
COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Atelectasis II: Pathophysiology
Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Pulmonary Edema II: Pathophysiology
Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...


